-
<![CDATA[Pirtobrutinib Improves PFS in Treatment-Naive CLL/SLL ]]>
09 Dec 2025 14:41 GMT
… survival (PFS) vs bendamustine (Treanda) plus rituximab (Rituxan; BR) … open-label phase 3 trial enrolled 282 patients … a significantly longer median treatment duration for pirtobrutinib (32 … receiving BR. Furthermore, treatment discontinuation due to TEAEs …
-
<![CDATA[Pirtobrutinib Wins Traditional FDA Approval in CLL and SLL]]>
03 Dec 2025 19:41 GMT
… Rituxan; IR) or bendamustine (Treanda) plus rituximab (BR). Notably … ;2 trial whose disease progressed following treatment with a …
Wierda is professor, medical director, and CLL … www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …
-
Unpacking the Latest Options Trading Trends in Teva Pharmaceutical Indus
30 Sep 2025 20:18 GMT
… has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … US-based generic and specialty drug distributor.
After a thorough review …
-
<![CDATA[Who Should Receive Mosunetuzumab/Polatuzumab Vedotin as MCL Treatment?]]>
27 Sep 2025 21:26 GMT
… label, randomized phase 2 trial (NCT03671018) evaluated mosunetuzumab-axgb … antibody, anthracycline, or bendamustine (Treanda) therapy, and a Bruton … the dosing for this trial determined?
Mosunetuzumab is … an [intravenous infusion] drug, but it is only …
-
<![CDATA[Determining Fitness Is Key in Mantle Cell Lymphoma Treatment Selection]]>
23 Sep 2025 21:53 GMT
… combinations that include bendamustine (Treanda) and rituximab (Rituxan) … Medicine (Hematology) at Yale University.
Transcript:
The current treatment … changed among most lymphoma doctors. That is based … although we have clinical trials ongoing here, so we …
-
Pirtobrutinib Improves PFS in Treatment-Naïve CLL/SLL Without 17p Deletions
08 Sep 2025 18:25 GMT
… 313 trial (NCT05023980) that evaluated pirtobrutinib monotherapy vs bendamustine (Treanda) plus … consistent with previously reported trials across various treatment settings.
"The … study [NCT05254743], at upcoming medical meetings and preparing global …
-
Spotlight on Multiple Myeloma Treatment and Pharmacist Support
14 Aug 2025 17:11 GMT
… 30-60 minutes for Treanda, 20 minutes for … /or administering vaccinations per current guidelines. …
10. FDA. Drugs@FDA: FDA-approved drugs [online database]. www.accessdata.fda.gov… #47;diagnosis-and-treatment/;clinical-trials-and-emerging-therapies. …
-
A Glimpse of Teva Pharmaceutical Indus's Earnings Potential
29 Jul 2025 17:23 GMT
… has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … -based generic and specialty drug distributor.
Teva Pharmaceutical Indus's Financial …
-
Treanda (bendamustine) and cost
30 May 2025 14:40 GMT
… and your doctor will discuss Treanda in regard to your treatment. The insurance … your doctor or another healthcare professional before taking any medication. The drug information …
-
Where Teva Pharmaceutical Indus Stands With Analysts
28 May 2025 22:33 GMT
… Pharmaceutical Indus
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug … has a portfolio of innovative medicines and biosimilars in three … and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract …